Literature DB >> 25684957

Snapshot of an integrated psychosocial gastroenterology service.

Sarah W Kinsinger1, Sarah Ballou1, Laurie Keefer1.   

Abstract

AIM: To characterize the patients utilizing a gastroenterology behavioral medicine service and examine the effect of treatment on health care utilization.
METHODS: Patients were referred by their gastroenterologists for psychological treatment during a 15 mo period. Patients seen for an intake with a psychologist completed the Brief Symptom Inventory (BSI) and a checklist of psychosocial concerns. A subset of patients with functional bowel disorders also completed a disease specific quality of life measure. Chart review was conducted to obtain information on type and frequency of sessions with the psychologist, the number of outpatient gastroenterology visits, and number of gastroenterology-related medical procedures during the 6 mo following psychological intake.
RESULTS: Of 259 patients referred for treatment, 118 (46%) completed an intake with a psychologist. Diagnoses included: irritable bowel syndrome (42%), functional dyspepsia (20%), inflammatory bowel diseases (20%), esophageal symptoms (10%), and "other" (8%). Demographic variables and disease type did not differentiate between those who did and did not schedule an intake. Mean t-scores for the BSI global score index and the depression, anxiety, and somatization subscales fell below the cutoff for clinical significance (t = 63). Treatments were predominantly gut-directed hypnosis (48%) and cognitive behavioral therapy (44%). Average length of treatment was 4 sessions. Among functional gastrointestinal (GI) patients, those patients who initiated treatment received significantly fewer GI-related medical procedures during the 6 mo following the referral than patients who did not schedule an intake [t (197) = 2.69, P < 0.01].
CONCLUSION: Patients are receptive to psychological interventions for GI conditions and there is preliminary evidence that treatment can decrease health-care utilization among patients with functional GI conditions.

Entities:  

Keywords:  Cognitive-behavioral therapy; Functional gastrointestinal disorders; Hypnosis; Irritable bowel syndrome; Psychological treatment

Mesh:

Year:  2015        PMID: 25684957      PMCID: PMC4323468          DOI: 10.3748/wjg.v21.i6.1893

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders.

Authors:  Olafur S Palsson; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.

Authors:  Robert J Hilsden; Marja J Verhoef; Allan Best; Gaia Pocobelli
Journal:  Am J Gastroenterol       Date:  2003-07       Impact factor: 10.864

3.  A national survey of practice patterns of gastroenterologists with comparison to the past two decades.

Authors:  M W Russo; B N Gaynes; D A Drossman
Journal:  J Clin Gastroenterol       Date:  1999-12       Impact factor: 3.062

4.  Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis.

Authors:  L Keefer; T H Taft; J L Kiebles; Z Martinovich; T A Barrett; O S Palsson
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

5.  Total costs of IBS: employer and managed care perspective.

Authors:  Brooks Cash; Sean Sullivan; Victoria Barghout
Journal:  Am J Manag Care       Date:  2005-04       Impact factor: 2.229

6.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 7.  Systematic review: the economic impact of irritable bowel syndrome.

Authors:  J M Inadomi; M B Fennerty; D Bjorkman
Journal:  Aliment Pharmacol Ther       Date:  2003-10-01       Impact factor: 8.171

Review 8.  Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action.

Authors:  Gabriel Tan; D Corydon Hammond; Gurrala Joseph
Journal:  Am J Clin Hypn       Date:  2005-01

Review 9.  New insights into the psychosocial aspects of irritable bowel syndrome.

Authors:  Richard Lea; Peter J Whorwell
Journal:  Curr Gastroenterol Rep       Date:  2003-08

10.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

View more
  7 in total

Review 1.  Non-cardiac Chest Pain: A Review for the Consultation-Liaison Psychiatrist.

Authors:  Kirsti A Campbell; Elizabeth N Madva; Ana C Villegas; Eleanor E Beale; Scott R Beach; Jason H Wasfy; Ariana M Albanese; Jeff C Huffman
Journal:  Psychosomatics       Date:  2016-12-09       Impact factor: 2.386

Review 2.  The Efficacy, Safety and Applications of Medical Hypnosis.

Authors:  Winfried Häuser; Maria Hagl; Albrecht Schmierer; Ernil Hansen
Journal:  Dtsch Arztebl Int       Date:  2016-04-29       Impact factor: 5.594

3.  Cognitive Behavioral Therapy for Insomnia in the Context of Cardiovascular Conditions.

Authors:  Samantha Conley; Nancy S Redeker
Journal:  Curr Sleep Med Rep       Date:  2015-07-10

4.  The specialized educational and psychological counseling in inflammatory bowel disease patients - a target or a challenge?

Authors:  Otilia Gavrilescu; Cristina Cijevschi Prelipcean; Mihaela Dranga; Camelia Soponaru; Catalina Mihai
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

Review 5.  Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights.

Authors:  Sarah W Kinsinger
Journal:  Psychol Res Behav Manag       Date:  2017-07-19

Review 6.  Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.

Authors:  Dipesh H Vasant; Peter J Whorwell
Journal:  Neurogastroenterol Motil       Date:  2019-02-27       Impact factor: 3.598

7.  Qualitative Analysis of Treatment Needs in Interstitial Cystitis/Bladder Pain Syndrome: Implications for Intervention.

Authors:  Lindsey C McKernan; Kemberlee R Bonnet; Michael T M Finn; David A Williams; Stephen Bruehl; W Stuart Reynolds; Daniel Clauw; Roger R Dmochowski; David G Schlundt; Leslie J Crofford
Journal:  Can J Pain       Date:  2020-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.